- Maxar Technologies adopted a poison pill structure in May 2019.
- The structure empowered the Board of Directors to be able to block any incoming shareholder or acquiror reaching a greater than 5.0% stake in the company.
- The poison pill expires today - and Maxar itself is a vastly more attractive acquisition now than in May 2019 - even adjusting for the increased share price.
- We anticipate plenty of interest in acquiring Maxar in the next 12-24 months and have the stock on our new M&A Hit List as a result.
For further details see:
Maxar Technologies' Poison Pill Expires Today - The Stock Joins Our M&A Hit List